Reduced price! Legacy Healthcare CG210 Anti Hair Loss Women's Lotion 80ml - Κλινικά Αποδεδειγμένη Αποτελεσματικότητα Στην Τριχόπτωση

Legacy Healthcare CG210 Anti Hair Loss Women's Lotion 80ml - Clinically Proven Efficacy In Hair Loss

By buying this product you can collect up to 2 loyalty points. Your cart will total 2 points that can be converted into a voucher of 0,50 €.


Preview the shipping fees

Please select your country and state (if not available please contact us immediately at info@zachospharmacy.gr)

Zachos Pharmacy

35,00 €

29,40 € Product Id: 4174

-16%

PRODUCT DETAILS

3770000506037

New

Legacy Healthcare CG210 Anti Hair Loss Women's Lotion 80ml - Clinically Proven Efficacy In Hair Loss

More details

Usually delivered within 2-3 working days

Content (ml)80
Pieces1

The CG210 is aimed at men and women experiencing hair loss problem. The unique and innovative mechanism of action of the CG210 is divided into three parts:

Molecular: Restoring the levels of antiapoptotic Bcl-2 protein near the normal range (+ 89%).
Cell: Increase of Langerhans cells (+ 74%) allowing the immune response and exert anti-inflammatory effects.
Cosmetic: Increased collagen levels (+ 67%) resulting in better implantation of the hair and reduce access external contaminants.
The result is that the hair loss returns to normal in less than 44 days.

These are confirmed by clinical study (Prof. Cuce, University of Sao Paulo, Brazil) in men with androgenetic alopecia who underwent biopsy of the scalp after 3-month topical administration CG210. Noteworthy is the fact that the clinical study showed no adverse effects from the use of CG210.

The Greek medical community welcomed the entrance of CG210 in Greek market. Mr. D.Rigopoulos, Professor of Dermatology-Venereology of the University of Athens and President of the Greek Society of Dermatology-Venereology, as the meeting coordinator, said: "I am delighted that we see coming new products, such as CG210, with a special mechanism action which followed from clinical studies with important conclusions. The results are encouraging and promising. The CG210 can be used in cases of seasonal hair loss, combined with food supplements, medications and medication intervals. Apart from androgenetic alopecia expect clinical results to more extensive use of the CG210, for example in patients on chemotherapy. "

Women

The androgenetic alopecia occurs in women at the end of the third decade of life (early) or postmenopausal (late) less often than men. At ages 20 to 30 years the percentage of women with androgenetic alopecia is estimated at 6-12%, while at ages greater than 70 years at 40-55%.

The dosage for male or female androgenetic alopecia is 5 to 10 sprays twice (2) daily for 9 months, followed by once (1) per day on the entire scalp (wet or dry). The 80ml bottle can lasts from 4 to 8 weeks. For occasional hair loss and thin or weak hair, the dosage is 5 to 10 sprays twice (2 times) daily all over the scalp (wet or dry). The minimum recommended treatment time is 6 weeks. The product is safe to use and well tolerated, and has been dermatologically tested. It is hypoallergenic, contains no preservatives, pigments, parabens or glycol. It is not oily and has low alcohol content.

No customer comments for the moment.

Write a review

Legacy Healthcare CG210 Anti Hair Loss Women's Lotion 80ml - Clinically Proven Efficacy In Hair Loss

Legacy Healthcare CG210 Anti Hair Loss Women's Lotion 80ml - Clinically Proven Efficacy In Hair Loss

Legacy Healthcare CG210 Anti Hair Loss Women's Lotion 80ml - Clinically Proven Efficacy In Hair Loss

Write a review

products in the same category: